Portal Innovations

Portal Innovations fuels life science breakthroughs with human, financial and physical capital

[Portal Innovations @portalinno]

Thanks to @EliLillyandCo for coming to Portal for an exclusive member reception hosted by @SheppardMullin. Portal’s @JohnLFlavin and Thomas Marron, at Eli Lilly, discussed how pharmaceutical companies and emerging biotech can work together to accelerate drug development.

[Portal Innovations @portalinno]

Thank you to the @JNJNews team for coming by Portal last week during #ASCO! J&J Innovation came by Portal Chicago to talk with startups in our ecosystem about what they look for when investing and partnering with innovative startups. J&J continues to be a fantastic partner!

[Portal Innovations @portalinno]

We're accepting venture fellow applications at Portal! This is a great opportunity for PhD students, postdocs, MD students, MBA students, and master's students to work alongside our investment team evaluating biotech and medtech companies. Learn more: https://t.co/oSAXojtWYB

[Portal Innovations @portalinno]

Our Founder and CEO, @JohnLFlavin was back on @CNBCFastMoney to talk about this year's annual #ASCO conference! In the segment, John discussed ADCs, T-Cell engagers, and vaccines which are now going after previously undruggable cancer targets. Take a look! https://t.co/geUyAzpkqi

[CNBC's Fast Money @CNBCFastMoney]

The world's largest oncology conference kicking off this week!

@portalinno CEO @JohnLFlavin on the important things to watch in the cancer therapy and vaccine space and why he expects more activity to happen soon.
https://t.co/pXV1b5fnr1

[Portal Innovations @portalinno]

Portal's Founder and CEO, @JohnLFlavin, moderated a panel discussion with the Astellas team to talk about the Astellas pipeline in oncology research, and their investment approaches that help improve outcomes for patients. Thanks to everyone who came! (2/2)

[Portal Innovations @portalinno]

Collaboration and innovation happens at Portal! During one of the biggest weeks in oncology and biotech research - the #ASCO conference - @AstellasUS joined us at Portal Chicago for a series of conversations and connections centered around the future of cancer research. (1/2)

[Portal Innovations @portalinno]

We love seeing this happening within the Houston life sciences ecosystem. Great work, @Mykalt45!

[Michael Torres @Mykalt45]

What an amazing time we had yesterday celebrating the win that was CrossBridgeBio. We’re building something special in Houston. I’m so grateful to have amazing people around me that have helped unlock tremendous opportunity for patients. We’re just getting started!

[Michael Torres @Mykalt45]

What an amazing time we had yesterday celebrating the win that was CrossBridgeBio. We’re building something special in Houston. I’m so grateful to have amazing people around me that have helped unlock tremendous opportunity for patients. We’re just getting started!

[Portal Innovations @portalinno]

We're excited to partner with @JNJNews at The New Jersey Innovation Hub, Powered by Portal, where J&J has secured the naming rights for our town hall area. Big things are happening in New Jersey and we can't wait to move in this summer!

[BINJE @BINJENEWS]

Innovation Collaboration: The Johnson & Johnson Exchange to anchor Portal Innovations’ 30,000-square-foot science incubator at HELIX, signaling major corporate commitment to New Brunswick’s life sciences ecosystem.

@JNJNews @JNJInnovation @portalinno

https://t.co/ulpTKQQj7C

[BiotechTV @BiotechTV]

𝐀𝐒𝐆𝐂𝐓 𝟐𝟎𝟐𝟔: @Mykalt45 isn't slowing down after selling his antibody-drug conjugate company to Eli Lilly. Here's his gene therapy play.

Full video: https://t.co/ye7YH2VnXj

[Portal Innovations @portalinno]

came together around a shared goal of growing innovation and fueling breakthroughs in Rhode Island. Ocean State Labs represents what can happen when public and private partners align behind a long-term vision. We're excited to build in Rhode Island! (2/2)

[Portal Innovations @portalinno]

It was great to officially celebrate the opening of Ocean State Labs alongside our partners across Rhode Island’s life sciences and innovation ecosystem. There was real energy in the room yesterday as founders, researchers, investors, industry leaders, and public officials (1/2)

[Portal Innovations @portalinno]

What an event at the UChicago Science Incubator, Powered by Portal! Bluefors hosted their opening event at the incubator to celebrate bringing their technology to help quantum-based companies to Hyde Park! Bluefors continues to be a fantastic member and partner at the UCSI.

[Portal Innovations @portalinno]

The latest pictures from The HELIX just came out, and they're fantastic! We're just a handful of weeks away from launching the New Jersey Innovation Hub, Powered by Portal and we can't wait to welcome innovative startups to the space. #njbio #biotech

[Portal Innovations @portalinno]

We recently hosted a great fireside in New Jersey that featured Portal's Founder and CEO, @JohnLFlavin and Chris Picariello, President of @JNJNews Innovation! It was great to chat about NJ's growing life sciences ecosystem and rich innovation history.

[HINJ @HINJ_ORG]

Congratulations to @portalinno founder John Flavin, as he and @JNJInnovation President Chris Picariello shared insights over a fireside chat discussing the future of life sciences and medical advances, reaffirming New Jersey’s reputation as the "Medicine Chest of the World."

[Portal Innovations @portalinno]

Great having @JohnLFlavin back on @BloombergTV to chat about our portfolio company, @CrossBridgeBio, getting acquired by @EliLillyandCo! In the segment, John discusses the science behind ADCs and Texas's growing life sciences market! https://t.co/WB31dk9QQ5

[Portal Innovations @portalinno]

@Mykalt45 Why is that? Any big news to report? 😂

[Portal Innovations @portalinno]

Congrats to our Houston portfolio startup, @CrossBridgeBio on being acquired by @EliLillyandCo! This is an exciting time for the future of ADCs - @Mykalt45 has built an amazing company and we're excited for its next phase. Read about the acquisition here: https://t.co/fkuvvC6obY